Swirsky Douglas J is a corporate insider (CHIEF FINANCIAL OFFICER) at GENVEC INC (GNVC) filing SEC Form 4 transactions. 74 transactions across 8 companies, totaling $236,328 in purchases and $22,061 in sales. Source: SEC EDGAR.
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
MAXCYTE, INC. MXCT | Purchase | 50,000 | $1.29 | $65K | 161,811 | 8/13/2025 Filed: 8/13/2025 | Filing → |
MAXCYTE, INC. MXCT | Sale | 6,939 | $3.18 | $22K | 111,811 | 3/18/2025 Filed: 3/20/2025 | Filing → |
MAXCYTE, INC. MXCT | Award | 150,000 | $3.29 | $494K | 150,000 | 3/14/2025 Filed: 3/18/2025 | Filing → |
MAXCYTE, INC. MXCT | Award | 37,500 | - | - | 118,750 | 3/14/2025 Filed: 3/18/2025 | Filing → |
| Award | 90,000 | $0.29 | $26K | 90,000 | 2/14/2025 Filed: 2/18/2025 | Filing → | |
| Award | 90,000 | - | - | 90,000 | 6/14/2024 Filed: 6/18/2024 | Filing → | |
MAXCYTE, INC. MXCT | Award | 225,000 | - | - | 225,000 | 3/15/2024 Filed: 3/19/2024 | Filing → |
MAXCYTE, INC. MXCT | Award | 81,250 | - | - | 81,250 | 3/15/2024 Filed: 3/19/2024 | Filing → |
| Award | 37,500 | $0.00 | $0 | 71,925 | 6/28/2023 Filed: 6/28/2023 | Filing → | |
MAXCYTE, INC. MXCT | Award | 350,000 | $0.00 | $0 | 350,000 | 3/27/2023 Filed: 3/28/2023 | Filing → |
| Award | 11,700 | $0.00 | $0 | 11,700 | 6/24/2022 Filed: 8/1/2022 | Filing → | |
| Purchase | 25,000 | $1.04 | $26K | 25,000 | 9/14/2021 Filed: 9/14/2021 | Filing → | |
| Award | 117,000 | $0.00 | $0 | 117,000 | 6/30/2021 Filed: 7/2/2021 | Filing → | |
NeuroBo Pharmaceuticals, Inc. NRBO | Award | 60,000 | $0.00 | $0 | 60,000 | 9/1/2020 Filed: 9/3/2020 | Filing → |
| Award | 80,000 | $0.00 | $0 | 80,000 | 6/24/2020 Filed: 6/25/2020 | Filing → | |
| Award | 9,750 | $0.00 | $0 | 9,750 | 6/13/2019 Filed: 6/14/2019 | Filing → | |
Fibrocell Science, Inc. FCSC | Award | 12,000 | - | - | 12,000 | 6/12/2019 Filed: 6/14/2019 | Filing → |
REXAHN PHARMACEUTICALS, INC. RNN | Purchase | 50,000 | $0.63 | $32K | 50,000 | 1/29/2019 Filed: 1/30/2019 | Filing → |
REXAHN PHARMACEUTICALS, INC. RNN | Award | 500,000 | $0.00 | $0 | 500,000 | 11/14/2018 Filed: 11/16/2018 | Filing → |
| Award | 19,500 | $0.00 | $0 | 19,500 | 10/12/2018 Filed: 10/15/2018 | Filing → |
Try asking...